S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
NYSE:OPY

Oppenheimer (OPY) Stock Forecast, Price & News

$39.19
+3.17 (+8.80%)
(As of 05/31/2023 ET)
Compare
Today's Range
$38.38
$39.70
50-Day Range
$35.90
$39.53
52-Week Range
$28.41
$49.32
Volume
141,426 shs
Average Volume
72,750 shs
Market Capitalization
$433.25 million
P/E Ratio
12.48
Dividend Yield
1.53%
Price Target
N/A

Oppenheimer MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
2.41% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.69
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$539,704 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.34 out of 5 stars

Finance Sector

548th out of 901 stocks

Security Brokers & Dealers Industry

14th out of 25 stocks


OPY stock logo

About Oppenheimer (NYSE:OPY) Stock

Oppenheimer Holdings, Inc. engages as a middle-market investment bank and full-service broker-dealer. It operates through the following segments: Private Client, Asset Management, Capital Markets, and Corporate/Other. The Private Client segment consists of commissions and a proportionate amount of fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees, net contributions from stock loan activities and financing activities, and direct expenses. The Asset Management segment consists of fee income earned on AUM from investment management services of Oppenheimer Asset Management Inc. The Capital Markets segment offers investment banking, institutional equities sales, trading, and research, taxable fixed income sales, trading, and research, public finance, and municipal trading. The Corporate/Other segment pertains to legal, compliance, accounting, and internal audit activities. The company was founded in 1881 and is headquartered in New York, NY.

Receive OPY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oppenheimer and its competitors with MarketBeat's FREE daily newsletter.

OPY Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Dr. Dennis Oppenheimer
Analyzing Oppenheimer (NYSE:OPY) and WisdomTree (NYSE:WT)
See More Headlines
Receive OPY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oppenheimer and its competitors with MarketBeat's FREE daily newsletter.

OPY Company Calendar

Last Earnings
7/30/2020
Ex-Dividend for 5/26 Dividend
5/11/2023
Dividend Payable
5/26/2023
Today
5/31/2023
Next Earnings (Estimated)
8/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Security brokers & dealers
Sub-Industry
Investment Banking & Brokerage
Sector
Finance
CUSIP
68379710
Employees
2,912
Year Founded
1950

Profitability

Net Income
$32.35 million
Pretax Margin
4.32%

Debt

Sales & Book Value

Annual Sales
$1.17 billion
Cash Flow
$7.78 per share
Book Value
$72.44 per share

Miscellaneous

Free Float
7,463,000
Market Cap
$433.25 million
Optionable
Optionable
Beta
1.15

Social Links


Key Executives

  • Albert Grinsfelder Lowenthal
    Chairman & Chief Executive Officer
  • Robert Steven Lowenthal
    President & Director
  • Leon Molokie
    Chief Operations Officer & Executive VP
  • Salvatore Agosta
    Chief Financial Officer
  • Brad M. Watkins
    Chief Financial Officer & Executive Vice President













OPY Stock - Frequently Asked Questions

How have OPY shares performed in 2023?

Oppenheimer's stock was trading at $42.33 at the start of the year. Since then, OPY stock has decreased by 7.4% and is now trading at $39.19.
View the best growth stocks for 2023 here
.

When is Oppenheimer's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 4th 2023.
View our OPY earnings forecast
.

How were Oppenheimer's earnings last quarter?

Oppenheimer Holdings Inc. (NYSE:OPY) issued its quarterly earnings results on Thursday, July, 30th. The financial services provider reported $1.34 EPS for the quarter. The financial services provider had revenue of $264.73 million for the quarter. Oppenheimer had a net margin of 3.16% and a trailing twelve-month return on equity of 4.68%.

How often does Oppenheimer pay dividends? What is the dividend yield for Oppenheimer?

Oppenheimer announced a quarterly dividend on Friday, April 28th. Shareholders of record on Friday, May 12th will be paid a dividend of $0.15 per share on Friday, May 26th. This represents a $0.60 annualized dividend and a dividend yield of 1.53%. The ex-dividend date is Thursday, May 11th.
Read our dividend analysis for OPY
.

What ETFs hold Oppenheimer's stock?

ETFs with the largest weight of Oppenheimer (NYSE:OPY) stock in their portfolio include AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC), Hartford Multifactor Small Cap ETF (ROSC).Vanguard U.S. Quality Factor ETF (VFQY),

Is Oppenheimer a good dividend stock?

Oppenheimer (NYSE:OPY) pays an annual dividend of $0.60 per share and currently has a dividend yield of 1.62%. The dividend payout ratio is 19.11%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for OPY.

What is Albert G. Lowenthal's approval rating as Oppenheimer's CEO?

113 employees have rated Oppenheimer Chief Executive Officer Albert G. Lowenthal on Glassdoor.com. Albert G. Lowenthal has an approval rating of 43% among the company's employees. This puts Albert G. Lowenthal in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Oppenheimer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oppenheimer investors own include AbbVie (ABBV), International Business Machines (IBM), Pfizer (PFE), Verizon Communications (VZ), Waddell & Reed Financial (WDR), Exxon Mobil (XOM), Boeing (BA), ChemoCentryx (CCXI), Salesforce (CRM) and Editas Medicine (EDIT).

What is Oppenheimer's stock symbol?

Oppenheimer trades on the New York Stock Exchange (NYSE) under the ticker symbol "OPY."

Who are Oppenheimer's major shareholders?

Oppenheimer's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (5.44%), Dimensional Fund Advisors LP (4.80%), State Street Corp (1.45%), AQR Capital Management LLC (1.44%), Geode Capital Management LLC (1.30%) and Bank of New York Mellon Corp (0.63%). Insiders that own company stock include A Winn Oughtred, Dennis P Mcnamara and Jeffrey J Alfano.
View institutional ownership trends
.

How do I buy shares of Oppenheimer?

Shares of OPY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Oppenheimer's stock price today?

One share of OPY stock can currently be purchased for approximately $39.19.

How much money does Oppenheimer make?

Oppenheimer (NYSE:OPY) has a market capitalization of $433.25 million and generates $1.17 billion in revenue each year. The financial services provider earns $32.35 million in net income (profit) each year or $3.14 on an earnings per share basis.

How many employees does Oppenheimer have?

The company employs 2,912 workers across the globe.

How can I contact Oppenheimer?

Oppenheimer's mailing address is 85 BROAD STREET, NEW YORK NY, 10004. The official website for the company is www.oppenheimer.com. The financial services provider can be reached via phone at (212) 668-8000, via email at info@opco.com, or via fax at 212-943-8728.

This page (NYSE:OPY) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -